USA - NASDAQ:TARA - US74365U1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TARA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-22 | Jones Trading | Initiate | Buy |
| 2025-04-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | ScotiaBank | Initiate | Sector Outperform |
| 2025-03-14 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-03-11 | LifeSci Capital | Initiate | Outperform |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-06 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-08 | Oppenheimer | Maintains | Outperform |
| 2021-06-04 | HC Wainwright & Co. | Initiate | Buy |
12 analysts have analysed TARA and the average price target is 25.5 USD. This implies a price increase of 448.98% is expected in the next year compared to the current price of 4.645.
The consensus rating for PROTARA THERAPEUTIC INC (TARA) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PROTARA THERAPEUTIC INC (TARA) is 12.